Pneumonia and inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients

Abstract

Background:

The prognostic impact of pneumonia and signs of systemic inflammation in patients with acute decompensated heart failure (ADHF) has not been fully elucidated yet. The aim of the present study was thus to investigate the association of pneumonia and the inflammation surrogate C-reactive protein with all-cause mortality in patients admitted for ADHF.

Methods:

We analysed data of 1939 patients admitted for ADHF. Patients were dichotomised according to the presence or absence of pneumonia. The primary endpoint of all-cause mortality was determined by death registry linkage.

Results:

In total, 412 (21.2%) patients had concomitant pneumonia. Median C-reactive protein levels were higher in patients with compared to patients without pneumonia (24.9 versus 9.8 mg/l, respectively; P<0.001). All-cause mortality was significantly higher in patients with pneumonia (P<0.001). In adjusted Cox regression models, pneumonia as well as C-reactive protein were independently associated with in-hospital mortality. Only C-reactive protein remained as independent predictor for long-term mortality.

Conclusion:

Pneumonia is relatively common in ADHF and a predictor for in-hospital mortality. However, inflammation in general seems to be more important than pneumonia itself for long-term prognosis. Compared to community-acquired pneumonia studies, C-reactive protein levels were rather low and therefore pneumonia might be over-diagnosed in ADHF patients.

Keywords

Acute decompensated heart failure pneumonia inflammation C-reactive protein prognosis

Get full access to this article

View all access options for this article.

References

Neumann

Biermann

Erbel

et al . Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106: 269–275.

Mozaffarian

Benjamin

et al .; Writing Group Members. Executive summary: Heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation 2016; 133: 447–454.

Solomon

Dobson

Pocock

et al . Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007; 116: 1482–1487.

Fonarow

Abraham

Albert

et al . Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008; 168: 847–854.

Michalsen

Konig

Thimme

Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998; 80: 437–441.

Opasich

Febo

Riccardi

et al . Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996; 78: 354–357.

Kapoor

et al . Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail 2016; 4: 464–472.

Salamanca-Bautista

Conde-Martel

Aramburu-Bodas

et al . Precipitating factors of heart failure admission: differences related to age and left ventricular ejection fraction. Int J Cardiol 2016; 219: 150–155.

Lieberman

Shvartzman

Korsonsky

et al . Diagnosis of ambulatory community-acquired pneumonia. Comparison of clinical assessment versus chest X-ray. Scand J Prim Health Care 2003; 21: 57–60.

10.

van Vugt

Verheij

de Jong

et al . Diagnosing pneumonia in patients with acute cough: clinical judgment compared to chest radiography. Eur Respir J 2013; 42: 1076–1082.

11.

Metlay

Schulz

et al . Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157: 1453–1459.

12.

Ewig

Hoffken

Kern

et al . [Management of adult community-acquired pneumonia and prevention – update 2016]. Pneumologie 2016; 70: 151–200.

13.

Mandell

Wunderink

Anzueto

et al . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27–S72.

14.

Watkins

Lemonovich

TL.

Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician 2011; 83: 1299–1306.

15.

Kalogeropoulos

Tang

Hsu

et al . High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail 2014; 20: 319–326.

16.

Damman

Tang

Testani

et al . Terminology and definition of changes renal function in heart failure. Eur Heart J 2014; 35: 3413–3416.

17.

Harford

Hara

MN.

Effect of pulmonary edema on susceptibility of mice to pneumococcal pneumonia. Proc Annu Meet Cent Soc Clin Res US 1947; 20: 15.

18.

LaForce

Mullane

Boehme

et al . The effect of pulmonary edema on antibacterial defenses of the lung. J Lab Clin Med 1973; 82: 634–648.

19.

Farr

Woodhead

Macfarlane

et al . Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med 2000; 94: 422–427.

20.

Torres

Peetermans

Viegi

et al . Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 2013; 68: 1057–1065.

21.

Young

Marrie

TJ.

Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia. Arch Intern Med 1994; 154: 2729–2732.

22.

Mabie

Wunderink

RG.

Use and limitations of clinical and radiologic diagnosis of pneumonia. Semin Respir Infect 2003; 18: 72–79.

23.

Chirinos

Zambrano

Chakko

et al . Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy. Am J Cardiol 2005; 95: 88–90.

24.

Windram

Loh

Rigby

et al . Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J 2007; 153: 1048–1055.

25.

Milo-Cotter

Cotter-Davison

Lombardi

et al . Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology 2011; 119: 96–105.

26.

Eurlings

Sanders-van Wijk

van Kimmenade

et al . Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea) risk score. J Am Coll Cardiol 2012; 60: 1668–1677.

27.

Mueller

Laule-Kilian

Christ

et al . Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 2006; 151: 845–850.

28.

Demissei

Cleland

O’Connor

et al . Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. Int J Cardiol 2016; 204: 164–171.

29.

Joffe

Justo

Mashav

et al . C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin Biochem 2009; 42: 1628–1634.

30.

Smith

Lipworth

Cree

et al . C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995; 108: 1288–1291.

31.

Hansson

Hedlund

Ortqvist

AB.

Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia. Scand J Clin Lab Invest 1997; 57: 111–118.

32.

Castro-Guardiola

Armengou-Arxe

Viejo-Rodriguez

et al . Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emergency ward. Eur J Intern Med 2000; 11: 334–339.